CFB and diabetic foot: The homodimer PDGF-BB regulates cell growth and division and promotes granulation tissue formation, re-epithelialization and wound angiogenesis.[55] Recombinant PDGF-BB topical gel (100μg/g), applied once daily, has been approved by FDA for the treatment of diabetic foot ulcers.[56, 57]